ADDvise repays the bond loan 2014/2019 (ISIN:SE0006245460)

ADDvise Group AB (publ) (”ADDvise” or the ”Company”) issued, in October 2014, a bond loan of maximum 100 MSEK with ISIN SE0006245460 and current outstanding amounts to 87 MSEK (the “Bond Loan”)

As previously communicated, for instance in the prospectus published on September 15 regarding the Company’s bond loan of maximum 240 MSEK 2017/2022, the above- mentioned bond loan are, inter alia, intended to reduce the financing cost to better reflect the general interest rate climate. The bond loan of maximum 240 MSEK 2017/2022 run with an interest rate of 7.25 per cent while the Bond Loan runs with an interest rate of 10.00 per cent.

ADDvise therefore announces that full repayment of the Bond Loan will be made through voluntary redemption, which means that that debtors will receive 101.0 per cent of the nominal amount plus accrued interest calculated from (but excluding) the most recent interest due date (and inclusive) the day of voluntary redemption. Repayment will be made on November 10, 2017 to those who are registered owners of the bond on the record date on November 3, 2017. At the time of payment, the debtors will receive 101.0 per cent of the nominal amount and accrued interest calculated until November 10, 2017.

The cost of the early repayment of the Bond Loan amounts to approximately 3.0 MSEK. Of which approximately 0.9 MSEK is compensation for early redemption to the bondholders and the remaining amount is the result of recurring advisory costs. Only 0.9 MSEK has a cash flow effect. The cost will be charged to ADDvise Group’s results in the fourth quarter of 2017.

Rikard Akhtarzand, VD
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

ADDvise Group AB (publ) är en ledande leverantör av utrustning till sjukvårds- och forskningsenheter. Koncernen består av ett 10-tal dotterbolag organiserade i två affärsområden, Lab och Sjukvård. Försäljning sker globalt. Koncernen har en tydlig förvärvsstrategi med syfte att höja aktieägarvärdet och bredda verksamheten – både geografiskt och produktmässigt. Koncernen omsätter ca 250 MSEK. ADDvise aktier är listade på Nasdaq First North Premier och Mangold Fondkommission AB, 08-503 015 50, är Bolagets Certified Adviser. Ytterligare information finns på www.addvisegroup.se.            

About Us

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier. Additional information is available at www.addvisegroup.com.

Subscribe

Documents & Links